Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Group Psychotherapy for Moderate-to-Severe Atopic Dermatitis
NCT07599878Completed
- Sponsor
- Semmelweis University
- Start
- Sep 2022
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in atopic dermatitis (AD) (3 arms), sponsored by Semmelweis University. Primary endpoints: Eczema Area and Severity Index at 14 weeks and SCORing Atopic Dermatitis at 14 weeks. Started Sep 2022; status: completed.
02
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07599878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07599878.